Amsterdam UMC

At Amsterdam UMC, research in Hemic and Lymphatic Diseases focuses on major blood cancers such as acute myeloid leukemia, myelodysplastic syndrome, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. These studies are designed to improve treatment effectiveness, deepen disease control, and support better long-term outcomes for patients with complex hematologic malignancies.

• Testing new treatment strategies for acute myeloid leukemia and myelodysplastic syndrome
• Evaluating approaches for lymphoma and chronic lymphocytic leukemia
• Studying ways to improve remission and survival in aggressive blood cancers

Several trials also explore precision medicine and post-treatment consolidation to help match therapy more closely to disease biology.

The site has active studies in Cardiovascular Diseases and Nutritional and Metabolic Diseases, including atrial fibrillation, acute coronary syndrome, atherosclerosis, vasospastic angina, hypertriglyceridemia, and portal hypertension. This work aims to assess new therapies, reduce cardiovascular risk, and improve management of metabolic complications.

• Evaluating treatments for atrial fibrillation and stroke prevention
• Studying therapies for coronary artery disease and vasospastic angina
• Testing options to lower triglycerides and address portal hypertension

Research at Amsterdam UMC also includes prevention-focused studies aimed at lowering future cardiovascular events in high-risk patients.

Clinical trials in Immune System Diseases, Skin and Connective Tissue Diseases, and Musculoskeletal Diseases include rheumatoid arthritis, atopic eczema, and dermatomyositis. These studies are focused on improving symptom control, refining treatment choices, and identifying better ways to match patients with therapies that work.

• Assessing new options for rheumatoid arthritis
• Comparing treatments for atopic eczema
• Evaluating therapy effectiveness in dermatomyositis

Some projects also explore tissue-based markers to better predict who will respond to treatment.

Research in Nervous System Diseases and Eye Diseases includes retinitis pigmentosa and Vanishing White Matter, along with studies in rare inherited conditions such as primary hyperoxaluria type 1 and non-transfusion dependent beta-thalassemia. The goal is to test new therapies, preserve function, and improve quality of life in patients with uncommon and often long-term diseases.

• Supporting vision preservation in retinitis pigmentosa
• Evaluating treatment safety in Vanishing White Matter
• Studying therapies for rare metabolic and blood disorders

These trials reflect a strong interest in conditions with limited treatment options and high unmet need.

The site also conducts studies in Virus Diseases and Microbiological Phenomena, including HIV-1 infection, monkeypox, and research on the intestinal microbiota. In addition, transplant-related work examines adolescent renal allografts and immune suppression strategies after kidney transplantation. These trials aim to improve infection control, support transplant outcomes, and better understand how the microbiome affects health.

• Testing new approaches for HIV-1 treatment
• Evaluating therapies for monkeypox
• Studying transplant care in adolescent renal allograft recipients

Additional work explores how antimicrobial treatment may influence the gut microbiome and broader patient health.

Within Neoplasms, several trials at Amsterdam UMC focus on endometrial cancer, advanced tumors, and molecularly defined cancers such as acute myeloid leukemia and lymphoma. The research is centered on improving cancer outcomes through more personalized treatment approaches and better disease monitoring.

• Studying recurrence reduction in endometrial cancer
• Evaluating response-focused strategies in advanced tumors
• Testing targeted treatment concepts based on tumor biology

These studies highlight a growing emphasis on precision oncology and tailoring care to the molecular features of each disease.